Beijing Strong Biotechnologies, Inc. (SZSE:300406) signed an Equity Transfer Agreement to acquire an additional 4.45% stake in Fuzhou Maixin Biotech. Co., Ltd. from Xinyu Yuanlang Management Consulting Partnership (Limited Partnership) for approximately CNY 130 million on August 29, 2022. Post completion, Beijing Strong Biotechnologies will hold 100% stake in Fuzhou Maixin Biotech.

As of July 31, 2022, Fuzhou Maixin Biotech. reported net assets of CNY 982.89 million and total assets of CNY 1116.13 million. The transaction has been approved by the chairman of the board and does not need to be submitted to the company's general meeting for consideration.